Sai Life Sciences Limited (NSE:SAILIFE)
India · Delayed Price · Currency is INR 1,126.00
+10.40 (0.93%)
May 11, 2026, 3:30 PM IST
Sai Life Sciences Revenue
Sai Life Sciences had revenue of 5.56B INR in the quarter ending December 31, 2025, with 26.53% growth. This brings the company's revenue in the last twelve months to 21.70B, up 39.61% year-over-year. In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B with 15.66% growth.
Revenue (ttm)
21.70B
Revenue Growth
+39.61%
P/S Ratio
11.00
Revenue / Employee
6.38M
Employees
3,401
Market Cap
238.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Piramal Pharma | 88.69B |
| Sagility | 67.37B |
| NATCO Pharma | 45.63B |
| Wockhardt | 34.84B |
Sai Life Sciences News
- 3 months ago - Sai Life Sciences Transcript: Q3 25/26 - Transcripts
- 6 months ago - Sai Life Sciences Transcript: Q2 25/26 - Transcripts
- 9 months ago - Sai Life Sciences Transcript: Q1 25/26 - Transcripts
- 1 year ago - Sai Life Sciences Transcript: Q4 24/25 - Transcripts
- 1 year ago - Sai Life Sciences Transcript: Q3 24/25 - Transcripts